Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0066
In Commercial Distribution

  • 07540127000505 ()
  • 07540127000499 ()
  • 07540127000512 ()

  • Area/Surface Area: 512 Square inch
CL1632

  • Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0065
In Commercial Distribution

  • 07540127000444 ()
  • 07540127000437 ()
  • 07540127000451 ()

  • Area/Surface Area: 256 Square inch
CL1616

  • Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0064
In Commercial Distribution

  • 07540127000413 ()
  • 07540127000406 ()
  • 07540127000420 ()

  • Area/Surface Area: 128 Square inch
CL0816

  • Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0063
In Commercial Distribution

  • 07540127000383 ()
  • 07540127000376 ()
  • 07540127000390 ()

  • Area/Surface Area: 36 Square inch
CL0606

  • Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0062
In Commercial Distribution

  • 07540127000352 ()
  • 07540127000345 ()
  • 07540127000369 ()

  • Area/Surface Area: 20 Square inch
CL0405

  • Wound-nonadherent dressing, absorbent, antimicrobial
TDS-1000 TendoNova Ocelot Nano System
Tendonova Corporation
TDS-1000
In Commercial Distribution

  • 00860008843548 ()


  • Soft-tissue ultrasonic surgical system handpiece, reusable
CHG 100 TendoNova Ocelot Nano Charger
Tendonova Corporation
CHG-100
In Commercial Distribution

  • 00860008843524 ()


  • Soft-tissue ultrasonic surgical system handpiece, reusable
RDU 1000 TendoNova Ocelot Nano Reusable Drive Unit
Tendonova Corporation
RDU-1000
In Commercial Distribution

  • 00860008843517 ()


  • Soft-tissue ultrasonic surgical system handpiece, reusable
Microlyte Ag VET Matrix, 4" x 4" (10 cm x 10 cm), Box of 5
IMBED BIOSCIENCES, INC.
99001
In Commercial Distribution

  • 00860001725759 ()

  • Area/Surface Area: 100 Square centimeter


  • Exudate-absorbent first aid dressing, hydrophilic-gel, antimicrobial
Microlyte Ag VET Matrix, 2" x 2" (5 cm x 5 cm), Box of 5
IMBED BIOSCIENCES, INC.
99000
In Commercial Distribution

  • 00860001725742 ()

  • Area/Surface Area: 25 Square centimeter


  • Exudate-absorbent first aid dressing, hydrophilic-gel, antimicrobial
< 1 ... 16 17 18 19 20 ... 130 >